Sort
23,748 grants matching “melanoma”
Project 2: Deciphering the Dynamic Evolution of the Tumor-Immune Interface
$459,005Forest M White · Massachusetts Institute Of Technology · U54 · FY2023 · CA
Image guided immunotherapy and targeted radionuclide therapy of metastatic melanoma
$458,957Carolyn J Anderson · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA
Genomic Analysis of Tumor Context Vulnerabilities in Human Metastatic Melanoma
$458,897Jeffrey M. Trent · Translational Genomics Research Inst · R01 · FY2008 · CA
Mechanism of Intratumoral Transport of Particulate Drugs
$458,897Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2022 · CA
Geisinger Clinical Oncology Program
$458,852Albert Michael Bernath · Geisinger Medical Center · U10 · FY2007 · CA
RNA-based Immunotherapy Targeting Antigens Unique to Brain Tumor Stem Cells
$458,810John H Sampson · Duke University · R01 · FY2011 · CA
Canine models for characterization, diagnosis, and treatment of human cancers using comparative canine-human transcriptomics
$458,591Gregory Tawa · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Human Leukemia Growth Inhibition by a Novel Retinoid
$458,562Joseph A Fontana · Wayne State University · R01 · FY2007 · CA
Restoration of Tumor Suppression Activity in Malignant Melanoma
$458,541David Joseph Weber · University Of Maryland Baltimore · R01 · FY2015 · CA
Restoration of Tumor Suppression Activity in Malignant Melanoma
$458,540David Joseph Weber · University Of Maryland Baltimore · R01 · FY2012 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$458,517Fox Chase Cancer Center · U10 · FY2000 · CA
Mechanisms of cancer mutations
$458,421Gerd P Pfeifer · Van Andel Research Institute · R01 · FY2024 · CA
Targeting apoptotic caspases to enhance cancer radiotherapy
$458,400Fang Li · Duke University · R01 · FY2022 · CA
Developmental Funds
$458,331Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P30 · FY2011 · CA
Determinants of Melanocyte Transformation and Melanoma Progression
$458,323Thomas J Hornyak · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Role of MetAP-2 in Angiogenesis and Wnt Signaling
$458,286Craig M Crews · Yale University · R01 · FY2007 · CA
Biomaterials for Targeted Modulation of Conventional Type 1 Dendritic Cells
$458,277Hua Wang · University Of Illinois At Urbana-Champaign · R01 · FY2022 · CA
Biospecimen Core/Immunologic Monitoring and Cellular Products Laboratory
$458,246Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P50 · FY2014 · CA
An innate immune checkpoint in cancer immunotherapy
$458,186Carla Rothlin · Yale University · R01 · FY2021 · CA
Study of Hepatic Arterial Infusion of Melphalan for Malignancy in the liver
$458,131Marybeth Hughes · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Cancer and Leukemia Group B
$458,112Dana-Farber Cancer Institute · U10 · FY2003 · CA
O-Glycosylation of Epidermal Growth Factor-like Modules
$457,994Robert S. Haltiwanger · State University New York Stony Brook · R01 · FY2009 · GM
DNA damage and repair in human melanocytes: relation to melanomagenesis mutations
$457,963Shisheng Li · Louisiana State Univ A&M Col Baton Rouge · R15 · FY2012 · CA
02 - Experimental Therapeutics
$457,959Suzanne Elizabeth Lapi · University Of Alabama At Birmingham · P30 · FY2025 · CA
Enhancing TIL populations and immunotherapy efficacy in melanoma by modulating fucosylation
$457,861Eric Kirk Lau · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA